SEAH, J.-A.; SRIDHAR, S.; WOOD, L.; BLAIS, N.; NORTH, S.; RAHIM, Y.; RUETHER, D.; BLACK, P.; ZLOTTA, A. R. Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process. Canadian Urological Association Journal, [S. l.], v. 7, n. 9-10, p. 312–8, 2013. DOI: 10.5489/cuaj.1506. Disponível em: Acesso em: 6 jun. 2023.